Nanomedicine and versatile therapies for cancer treatment

Show simple item record

dc.contributor.author Shukla, Aparna
dc.contributor.author Maiti, Pralay
dc.date.accessioned 2023-04-20T05:25:54Z
dc.date.available 2023-04-20T05:25:54Z
dc.date.issued 2022-09
dc.identifier.issn 26882663
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/2115
dc.description This paper is submitted by the author of IIT (BHU), Varanasi en_US
dc.description.abstract The higher prevalence of cancer is related to high rates of mortality and morbidity worldwide. By virtue of the properties of matter at the nanoscale, nanomedicine is proven to be a powerful tool to develop innovative drug carriers with greater efficacies and fewer side effects than conventional therapies. In this review, different nanocarriers for controlled drug release and their routes of administration have been discussed in detail, especially for cancer treatment. Special emphasis has been given on the design of drug delivery vehicles for sustained release and specific application methods for targeted delivery to the affected areas. Different polymeric vehicles designed for the delivery of chemotherapeutics have been discussed, including graft copolymers, liposomes, hydrogels, dendrimers, micelles, and nanoparticles. Furthermore, the effect of dimensional properties on chemotherapy is vividly described. Another integral section of the review focuses on the modes of administration of nanomedicines and emerging therapies, such as photothermal, photodynamic, immunotherapy, chemodynamic, and gas therapy, for cancer treatment. The properties, therapeutic value, advantages, and limitations of these nanomedicines are highlighted, with a focus on their increased performance versus conventional molecular anticancer therapies. en_US
dc.description.sponsorship The research support grant of Tata Innovation Fellowship (sanction no. BT/HRD/35/01/02/2020) is highly acknowledged. en_US
dc.language.iso en en_US
dc.publisher John Wiley and Sons Inc en_US
dc.relation.ispartofseries MedComm;Article number e163
dc.subject administration routes en_US
dc.subject cancer en_US
dc.subject controlled drug delivery en_US
dc.subject nanomedicines en_US
dc.title Nanomedicine and versatile therapies for cancer treatment en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search in IDR


Advanced Search

Browse

My Account